What Is Aethlon Medical, Inc. (AEMD) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Aethlon Medical, Inc. at $0.67. With an estimated intrinsic value of $1.73 and 3 of 5 models pointing higher, the average implied return is +157.9%. The most optimistic model, CUCE, places fair value at $3.45 (+415.4%), while ML-RIV — the most conservative — estimates $0.40 (-40.7%). This +456.1% gap reflects genuine analytical uncertainty about Aethlon Medical, Inc.'s intrinsic worth.
What Do the Models Say About AEMD?
5 of 13 models are currently active for AEMD. Of these, 4 models suggest upside while 1 model suggests overvaluation. The Bayesian DCF estimates AEMD's intrinsic value at $1.54, implying +130.5% upside from the current price. See which stocks rank higher →
How Does AEMD Rank in Medical Devices?
Among 10 Medical Devices stocks, AEMD ranks #7 by Quality of Company score. CirclFi's QOC score of 4.9/10 evaluates 32 fundamental signals. A score of 4.9 reflects mixed fundamentals.
As a pharmaceutical industry, Aethlon Medical, Inc. operates in a sector where biosimilar competition timeline is a critical driver of valuation. Investors evaluating AEMD should weigh these sector-specific dynamics alongside our model-derived fair values.
Is AEMD a Value Trap?
CirclFi's Value Trap algorithm assigns AEMD a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
5 of 13 models are active for Aethlon Medical, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Aethlon Medical, Inc.'s fundamental quality profile registers 4.9/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +456.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every AEMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across AEMD's 5 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad